DD281600A5 - Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten - Google Patents

Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten Download PDF

Info

Publication number
DD281600A5
DD281600A5 DD88316492A DD31649288A DD281600A5 DD 281600 A5 DD281600 A5 DD 281600A5 DD 88316492 A DD88316492 A DD 88316492A DD 31649288 A DD31649288 A DD 31649288A DD 281600 A5 DD281600 A5 DD 281600A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
compound
hydrogen
alkyl
acid
Prior art date
Application number
DD88316492A
Other languages
German (de)
English (en)
Inventor
Banavara L Mylari
William J Zembrowski
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD281600A5 publication Critical patent/DD281600A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DD88316492A 1987-06-09 1988-06-07 Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten DD281600A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5989987A 1987-06-09 1987-06-09

Publications (1)

Publication Number Publication Date
DD281600A5 true DD281600A5 (de) 1990-08-15

Family

ID=22026001

Family Applications (3)

Application Number Title Priority Date Filing Date
DD88326849A DD280320A5 (de) 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten
DD88326850A DD280323A5 (de) 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DD88316492A DD281600A5 (de) 1987-06-09 1988-06-07 Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DD88326849A DD280320A5 (de) 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol oder anderen heterocyclischen seitenketten
DD88326850A DD280323A5 (de) 1987-06-09 1988-06-07 Herstellung von zwischenprodukten der oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten

Country Status (26)

Country Link
EP (1) EP0295051B1 (zh)
JP (1) JPH0676391B2 (zh)
KR (1) KR900004698B1 (zh)
CN (1) CN1024347C (zh)
AT (1) ATE90347T1 (zh)
AU (1) AU593742B2 (zh)
CA (1) CA1321791C (zh)
CS (1) CS274628B2 (zh)
DD (3) DD280320A5 (zh)
DE (1) DE3881583T2 (zh)
DK (1) DK309988A (zh)
EG (1) EG18613A (zh)
ES (1) ES2040853T3 (zh)
FI (1) FI93835C (zh)
HU (1) HU205108B (zh)
IE (1) IE61499B1 (zh)
IL (1) IL86660A0 (zh)
MY (1) MY103573A (zh)
NO (1) NO176317C (zh)
NZ (1) NZ224937A (zh)
PH (1) PH25928A (zh)
PL (1) PL157690B1 (zh)
PT (1) PT87669B (zh)
SU (1) SU1678208A3 (zh)
YU (1) YU46696B (zh)
ZA (1) ZA884075B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids
WO1989006651A1 (en) * 1988-01-19 1989-07-27 Pfizer Inc. 1h-indazole-3-acetic acids as aldose reductase inhibitors
US4904782A (en) * 1988-02-29 1990-02-27 Pfizer Inc. Process for the production of phthalazineacetic acid ester derivatives and a novel intermediate
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
FR2647676A1 (fr) * 1989-06-05 1990-12-07 Union Pharma Scient Appl Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
US5304557A (en) * 1989-12-15 1994-04-19 Pfizer Inc. Substituted oxoophthalazinyl acetic acids and analogs thereof
US5064830A (en) * 1990-08-02 1991-11-12 Pfizer Inc. Lowering of blood uric acid levels
WO1992003432A1 (en) * 1990-08-28 1992-03-05 Pfizer Inc. 3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-3h-phythalazin-1-ylacetic acid monohydrate
EP0582643A1 (en) * 1991-03-28 1994-02-16 Pfizer Inc. Pyridazinone acetic acids
FR2682108B1 (fr) * 1991-10-07 1994-01-07 Lipha Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
EP0652213B1 (en) * 1993-10-06 1997-08-27 SUMIKA FINE CHEMICALS Co., Ltd. Method for producing alkyl 3-phthalidylideneacetate
US5700819A (en) * 1994-11-29 1997-12-23 Grelan Pharmaceutical Co., Ltd. 2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
EP0982306A3 (en) * 1998-08-21 2000-07-05 Pfizer Products Inc. Polymorph of zopolrestat monohydrate
SG82702A1 (en) * 1999-09-28 2001-08-21 Ebauchesfabrik Eta Ag Timepiece including a movement mounted in a casing ring
CN116970317B (zh) * 2023-03-20 2024-06-25 安徽庆丰涂料科技有限公司 可呼吸的负离子抗菌涂料及其加工工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47592B1 (en) * 1977-12-29 1984-05-02 Ici Ltd Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
JPS5931509B2 (ja) * 1979-06-06 1984-08-02 昭和電工株式会社 ３−ヒドロキシ−３−メチルフタリド又はその核置換体の製造法
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.

Also Published As

Publication number Publication date
KR900004698B1 (ko) 1990-07-02
KR890000476A (ko) 1989-03-14
FI882722A0 (fi) 1988-06-08
CS392488A2 (en) 1990-08-14
NO882516L (no) 1988-12-12
PH25928A (en) 1991-12-19
DE3881583T2 (de) 1993-09-16
DK309988D0 (da) 1988-06-08
FI882722A (fi) 1988-12-10
CS274628B2 (en) 1991-09-15
CA1321791C (en) 1993-08-31
ZA884075B (en) 1990-02-28
NO176317C (no) 1995-03-15
PT87669B (pt) 1992-09-30
CN88103507A (zh) 1988-12-28
HU205108B (en) 1992-03-30
EP0295051A2 (en) 1988-12-14
IE61499B1 (en) 1994-11-02
JPS643173A (en) 1989-01-06
ES2040853T3 (es) 1993-11-01
CN1024347C (zh) 1994-04-27
AU593742B2 (en) 1990-02-15
IE881716L (en) 1988-12-09
DD280323A5 (de) 1990-07-04
DD280320A5 (de) 1990-07-04
PL272899A1 (en) 1989-07-10
PT87669A (pt) 1988-07-01
YU111188A (en) 1989-12-31
NZ224937A (en) 1991-01-29
EP0295051B1 (en) 1993-06-09
NO882516D0 (no) 1988-06-08
MY103573A (en) 1993-08-28
NO176317B (no) 1994-12-05
EP0295051A3 (en) 1989-03-22
PL157690B1 (en) 1992-06-30
AU1749188A (en) 1988-12-15
YU46696B (sh) 1994-04-05
EG18613A (en) 1993-08-30
IL86660A0 (en) 1988-11-30
JPH0676391B2 (ja) 1994-09-28
ATE90347T1 (de) 1993-06-15
FI93835C (fi) 1995-06-12
DE3881583D1 (de) 1993-07-15
SU1678208A3 (ru) 1991-09-15
DK309988A (da) 1988-12-10
FI93835B (fi) 1995-02-28

Similar Documents

Publication Publication Date Title
DD281600A5 (de) Herstellung von oxophthalazinyl-essigsaeuren mit benzothiazol- oder anderen heterocyclischen seitenketten
DE69230163T2 (de) Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
DE3881408T2 (de) Thiazolidinon-Derivate, ihre Herstellung und ihre Verwendung.
DE3689924T2 (de) Durch eine heterocyclische Gruppe substituierte Phenoxyalkylisoxazole und ihre Verwendung als antivirale Mittel.
DE2432410C2 (de) 2-[4-(Imidazo[1,2a][pyridin-2-yl)-phenyl]-propionsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE69513332T2 (de) (Thia)cycloalkyl(b)indolderivate als 5-lipoxygenase Inhibitoren
DE69432542T2 (de) Tetraderivate, ihre Herstellung und Verwendung
DD253823A5 (de) Verfahren zur herstellung neuartiger thienopyridone
DE69319391T2 (de) 1,2,4-Oxadiazolyl oder 1,2,4-Thiadiazolyl-Derivate als Angiotensin II Antagonisten
DE2824575C2 (de) 4-substituierte Methylen-1,3-dithietan-2-carbonsäure oder ihre niederen Alkylester, Verfahren zu ihrer Herstellung und ihre Verwendung als Acylierungsmittel
DE69800699T2 (de) Verbindungen
DE10115408A1 (de) Benzofuran-Derivate
DE60037766T2 (de) Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivaten und 3-Aminothiophen Derivate
EP0350437B1 (de) 3,4-Disubstituierte Phenyl-Heterocyclen und deren Verwendung
DD254001A5 (de) Verfahren zur herstellung von heterocyclischen oxophtalazinylessigsaeuren
DE2624344C2 (de) Verfahren zur Herstellung von in 1-Stellung unsubstituierten 3-(2-Hydroxyäthyl)-indol-Derivaten
DE2841644A1 (de) 3(tetrazol-5-yl)-1-azaxanthone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
JP2001515066A (ja) 置換された２−ニトログアニジン誘導体の製造方法
EP0003360B1 (de) Neue Azathianaphthalinderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung
DE69705640T2 (de) Verfahren zur herstellung von heteroaryl-phenylalaninen
DE69714076T2 (de) Herstellung von thiazolen
EP0231744B1 (de) Substituierte Pyrrol-1-ylphenyldihydropyridazinone, ihre Herstellung und Verwendung
CH660011A5 (de) Substituierte carboxy-thiazolo-(3,2-a)-pyrimidin-derivate.
DE2759959C2 (zh)
EP0562382B1 (de) Verfahren zur Herstellung von Isoxazol-3,4-dicarbonsäurederivaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee